When the B-cell lymphoma-derived DC-SIGN+ Raji cell line was used as the virus capture cell line, we found that all three variants of Griffithsin significantly increased DC-SIGN-mediated trans-infectivity. The gene discussed is CD209; the disease is B-cell non-Hodgkin lymphoma.